Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
Phytomedicine. 2023 Jan;108:154510. doi: 10.1016/j.phymed.2022.154510. Epub 2022 Oct 18.
The liver plays an important role in regulating the metabolic processes and is the most frequently targeted organ by toxic chemicals. Acetaminophen (APAP) is a well-known anti-allergic, anti-pyretic, non-steroidal anti-inflammatory drug (NSAID), which upon overdose leads to hepatotoxicity, the major adverse event of this over-the-counter drug.
APAP overdose induced acute liver injury is the second most common cause that often requires liver transplantation worldwide, for which N-acetyl cysteine is the only synthetic drug clinically approved as an antidote. So, it was felt that there is a need for the novel therapeutic approach for the treatment of liver diseases with less adverse effects. This review provides detailed analysis of the different plant extracts; phytochemicals and herbal formulations for the amelioration of APAP-induced liver injury.
The data was collected using different online resources including PubMed, ScienceDirect, Google Scholar, Springer, and Web of Science using keywords given below.
Over the past decades various reports have revealed that plant-based approaches may be a better treatment choice for the APAP-induced hepatotoxicity in pre-clinical experimental conditions. Moreover, herbal compounds provide several advantages over the synthetic drugs with fewer side effects, easy availability and less cost for the treatment of life-threatening diseases.
The current review summarizes the hepatoprotective effects and therapeutic mechanisms of various plant extracts, active phytoconstituents and herbal formulations with potential application against APAP induced hepatotoxicity as the numbers of hepatoprotective natural products are more without clinical relativity. Further, pre-clinical pharmacological research will contribute to the designing of natural products as medicines with encouraging prospects for clinical application.
肝脏在调节代谢过程中起着重要作用,是毒性化学物质最常攻击的器官。对乙酰氨基酚(APAP)是一种众所周知的抗过敏、解热、非甾体抗炎药(NSAID),过量使用会导致肝毒性,这是这种非处方药的主要不良反应。
APAP 过量引起的急性肝损伤是全球第二常见的需要肝移植的原因,为此,N-乙酰半胱氨酸是唯一一种临床上被批准为解毒剂的合成药物。因此,人们认为需要一种新的治疗方法来治疗肝脏疾病,以减少不良反应。本综述详细分析了不同的植物提取物;植物化学物质和草药配方对 APAP 诱导的肝损伤的改善作用。
使用不同的在线资源,包括 PubMed、ScienceDirect、Google Scholar、Springer 和 Web of Science,使用以下关键词收集数据。
在过去几十年中,各种报告表明,植物方法可能是临床前实验条件下治疗 APAP 诱导的肝毒性的更好选择。此外,与合成药物相比,草药化合物具有更少的副作用、易于获得和更低的治疗致命疾病的成本等优势。
本综述总结了各种植物提取物、活性植物化学成分和草药配方的保肝作用及其治疗机制,具有对抗 APAP 诱导的肝毒性的潜在应用,因为具有保肝作用的天然产物数量更多,而没有临床相关性。此外,临床前药理学研究将有助于设计具有临床应用前景的天然药物。